COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 9th, 2009 • Supergen Inc • Pharmaceutical preparations • Delaware
This Common Stock Purchase Agreement (this “Agreement”) is made as of October 22, 2009 (the “Effective Date”) by and between SuperGen, Inc., a Delaware corporation (the “Company”) and SmithKline Beecham Corporation, doing business as GlaxoSmithKline, a Pennsylvania corporation (the “Purchaser”).
AMENDED & RESTATED COMMERCIAL RESEARCH AND LICENSE AGREEMENTCommercial Research and License Agreement • November 9th, 2009 • Supergen Inc • Pharmaceutical preparations • Delaware
This Amended & Restated Commercial Research and License Agreement (“Agreement”) is entered into as of November 6, 2009 (“Execution Date”), by and between GlaxoSmithKline LLC, a Delaware limited liability company (formerly known as SmithKline Beecham Corporation d/b/a GlaxoSmithKline), with its principal place of business located at One Franklin Plaza, Philadelphia, Pennsylvania 19101 (“GSK”) and SuperGen, Inc., a company organized under the laws of the State of Delaware, with its principal place of business located at 4140 Dublin Blvd., Suite 200, Dublin, CA 94568 (“SGI”). Each of GSK and SGI hereinafter referred to as a “Party” and together, the “Parties”.
